Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India

PHASE3CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

April 22, 2021

Primary Completion Date

July 1, 2022

Study Completion Date

August 1, 2022

Conditions
COVID-19
Interventions
DIETARY_SUPPLEMENT

Vitamin D3 (cholecalciferol)

180,000 international units (IU) of vitamin D3 at enrollment, followed by 2000 IU once per day from enrollment to 8 weeks

DIETARY_SUPPLEMENT

Zinc (zinc gluconate)

40mg of zinc gluconate taken once per day from enrollment to 8 weeks

DIETARY_SUPPLEMENT

Zinc (zinc gluconate) & Vitamin D (cholecalciferol)

180,000 IU of vitamin D3 at enrollment, followed by 2000 IU of vitamin D3 and 40mg of zinc gluconate once per day from enrollment to 8 weeks

OTHER

Placebo

Placebo vitamin D bolus at enrollment followed by placebo daily vitamin D maintenance doses and placebo daily zinc supplements.

Trial Locations (2)

Unknown

Saifee Hospital, Mumbai

King Edward Memorial (KEM) Hospital, Pune

Sponsors
All Listed Sponsors
collaborator

Foundation for Medical Research

OTHER

collaborator

University Health Network, Toronto

OTHER

lead

Harvard School of Public Health (HSPH)

OTHER